Skip to main content

Advertisement

SpringerLink
Log in

What has been overlooked on study of Chinese materia medica in the West?

  • Feature Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Chinese materia medica (CMM), including Chinese herbal, animal, and mineral medicine, has been widely researched in the past century for their biological and pharmacological activities. However, their mechanism and clinical efficacy studies did not always give expected results. For example, the most commonly used Chinese herb for menstrual disorders, Radix Angelicae sinensis, showed neither estrogenic nor progesteronic activity in laboratory and clinical studies. Its efficacy should not be denied simply based on such results, because it is mostly used together with other herbs in formulae. Moreover, its regulation on menstruation may take effect through other mechanisms, such as regulation of blood circulation. The key difference of Chinese medicine (CM) from conventional medicine is its unique holistic view on human body and diseases. CMM is mostly applied in clinic in the form of formulae. Study on individual CMM, simply using methods for development of conventional drugs, is unable to thoroughly reveal the power of CMM formulae. The reason may partly result from improper design due to the lack understanding about application principle of CMMs in CM, and/or to current lack of knowledge about the causes of some symptoms and diseases. This paper will introduce the importance of qi and blood in CM etiology and pathology, Zheng differentiation, formulation of CMMs, and explain why one formula can treat different diseases and one disease can be treated with different formulae. Examples in the paper will demonstrate that proper studies on Zheng and its corresponding clinically proven formulae could help scientists find new direction to explain and treat symptoms and diseases that so far modern medicine has been unable to, provided that the designer properly understands CM theories, etiology and pathology of CM, as well as modern medicine. Strategy suggestions about research methods for CMM and its formulae will be given at the end.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tu YY. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217᾿220.

    Article  CAS  PubMed  Google Scholar 

  2. Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 2001;6:S1–S2.

    Article  Google Scholar 

  3. State Administration of Traditional Chinese Medicine. Chinese herbal medicine. Shanghai: Shanghai Science and Technology Publisher;1999.

    Google Scholar 

  4. Liu JL, Burdette JE, Xu HY, Gu C, van Breemen RB, Bhat KP, et al. Evaluation of estrogenic activities of plant extracts on the potential treatment of menopausal. J Agric Food Chem 2001;49:2472᾿479.

    Article  CAS  PubMed  Google Scholar 

  5. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997;68:981᾿86.

    Article  CAS  PubMed  Google Scholar 

  6. Liu JH. Traditional herbal medicine research methods: identification, analysis, bioassay, and pharmaceutical and clinical studies. Hoboken: John Wiley & Son:2011:8᾿2.

    Book  Google Scholar 

  7. Cheung F. TCM: made in China. Nature 2011:480:S82–S83.

    Article  CAS  PubMed  Google Scholar 

  8. Xu ZG. Modernization: one step at a time. Nature 2011;480:S90–S92.

    Article  CAS  PubMed  Google Scholar 

  9. Tian P. Convergence: where West meets East. Nature 2011;480:S84–S86.

    Article  CAS  PubMed  Google Scholar 

  10. Chen SL, Song JY, Sun C, Xu J, Zhu YJ, Verpoorte R, et al. Herbal genomics: examining the biology of traditional medicine. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing Office 2015:S27–S29.

  11. Guo DA, Wu WY, Ye M, Liu X, Cordell GA. A holistic approach to the quality control of traditional Chinese medicine. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing office. 2015:S29–S34.

  12. Gilbert N. Regulations: herbal medicine rule book. Nature 2011;480:S98–S99.

    Article  CAS  PubMed  Google Scholar 

  13. Jiang J. Patents: protecting China’s national treasure. Nature 2011;480:S93.

    Article  CAS  PubMed  Google Scholar 

  14. Liu L, Leung EL, Tian XY. Perspective: the clinical trial barriers. 2011;480:S100.

    CAS  Google Scholar 

  15. Sakurai M. Perspective: herbal dangers. Nature 2011;480:S97.

    Article  CAS  PubMed  Google Scholar 

  16. Williamson EM, Chan K, Xu QH, Nachtergaet A, Bunel V, Zhang, L. et al. Evaluating the safety of herbal medicines: integrated toxicological approaches. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing Office. 2015:S47–S49.

  17. Yang ZF, Leung HEL, Liu L, Jiang ZH, Zhong NS. Developing influenza treatments using traditional Chinese medicine. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing Office. 2015:S35–S37.

  18. Lau GBS, Yue GGK, Fung KP, Tan NH, Leung, PC. The potential role of Chinese herbal medicine in cancer treatment. The art and science of Traditional Medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing office. 2015:S45–S47.

  19. Liu RH, Runyon RS, Wang YH, Oliver SG, Fan TP, Zhang WD. Deciphering ancient combinatorial formulations: the Shexiang Baoxin Pill. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing office. 2015:S40–S42.

  20. Lam W, Liu SH, Jiang Z, Cheng YC. Lessons from the development of the traditional Chinese medicine formula PHY906. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing Office. 2015:S43–S44.

  21. Zhao XF, Zheng XH, Fan TP, Li ZJ, Zhang YY, Zheng JB. A novel drug discovery strategy inspire by traditional medicine philosophies. The art and science of traditional medicine. Part 2: Multidisciplinary approaches for studying traditional medicine. Science/AAAS Custom Publishing Office. 2015:S38–S40.

  22. Cheng XN, ed. Chinese acupuncture and moxibustion (Revised edition). Beijing: Foreign Languages Press;1999:51᾿9, 254᾿61.

  23. Ray O. The revolutionary health science of psychoendoneuroimmunology: a new paradigm for understanding health and treating illness. Ann NY Acad Sci 2004;1032:35᾿1.

    Article  PubMed  Google Scholar 

  24. Shen YJ, Chen CX, eds. Pharmacology of Chinese material medica. In: Shen YJ, Chen CY, eds. Pharmacology of Chinese material medica. Shanghai: Shanghai Science and Technology Press; 2008:117,186.

  25. Appleton N, ed. Stopping inflammation: relieving the cause of degenerative diseases. Garden City Park: Square One Publishers;2005:57᾿19.

  26. Yan DX, ed. Aging & blood stasis—A new TCM approach to geriatrics. Boulder: Blue Poppy Press;1995:1᾿8.

  27. Chang JB, Prasad K, Olsen ER, eds. Textbook of angiology. New York: Springer Verlag;2000.

    Google Scholar 

  28. Callahan AS, ed. The next medical revolution—angiology. St. Albans: Altman Publishing;2004:1᾿.

  29. Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu AP, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 2012;140:634᾿42.

    Article  PubMed  Google Scholar 

  30. Deng TT, Han ZQ, eds. Diagnosis of traditional Chinese medicine. Shanghai: Shanghai Science and Technology Publishing House; 1983:122.

    Google Scholar 

  31. Zheng HS, Jiang J, Jia W. Review of modern research of Kidney yang deficiency in Chinese medicine. Liaoning J Tradit Chin Med (Chin) 2007;34:1014᾿015.

    Google Scholar 

  32. Wang YH, Xu AL. Zheng: a systems biology approach to diagnosis and treatment. The art and science of traditional medicine. Part 1: TCM today—a case for integration. Science/AAAS Custom Publishing Office. 2015:S13-S15.

  33. Liu JH. Research on Chinese materia medica should be based on clinical practice—Suggestions about study on Chinese herbal formulae. Clin J Chin Med (Chin) 2014;6(27):4᾿.

    Google Scholar 

  34. Liu JH, Zschocke S, Reininger E, Bauer R. Inhibitory effect of Angelica pubescens on 5-lipooxygenase and cyclooxygenase. Planta Med 1998;64:525᾿29.

    Article  CAS  PubMed  Google Scholar 

  35. Liu JH, Burdette JE, Sun Y, Deng S, Schlecht SM, Zeng W, et al. Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnuscastus L. (chaste berry). Phytochemistry 2004;11:18᾿3.

    CAS  Google Scholar 

  36. Bensky D, Barolet R. Chinese herbal medicine: formula & strategies. Seattle: Eastland Press;1990:4᾿.

    Google Scholar 

  37. Bensky D, Clavey S, Stoger E. Chinese herbal medicine: Materia Medica. 3rd ed. Seattle: Eastland Press; 2004:14᾿5.

    Google Scholar 

  38. Zhao DM. Study on the compatibility of composite herbal medicines of the Wuzhuyu Decoction. World Sci-Tech Res Develop 1999;21:46᾿0.

    Google Scholar 

  39. Shen YJ, Chen CY, eds. Pharmacology of Chinese material medica. Shanghai: Shanghai Science and Technology Press;2008:187᾿91.

    Google Scholar 

  40. Kang SB, Yuan J eds., ZHANG Zhong-jing medical formula essentials. Shijiazhuang: Hebei Science and Technology Press;2004.

    Google Scholar 

  41. Sakamoto S, Yoshino H, Shirahata Y, Shimodairo K, Okamoto R. Pharmacotherapeutic effects of Kuei-chih-fuling-wan (Keishi-bukuryo-gan) on human uterine myomas. Am J Chin Med 1992;20,313᾿17.

    Article  CAS  PubMed  Google Scholar 

  42. Mori T, Sakamoto S, Singtripop T, Park MK, Kato T, Kawashima S, et al. Suppression of spontaneous development of uterine adenomyosis by a Chinese herbal medicine, keishibukuryo-gan, in mice. Planta Med 1993;59:308᾿11.

    Article  CAS  PubMed  Google Scholar 

  43. Chen JT, Shiraki M. Menopausal hot flash and calciotonin gene-related peptide; effect of Keishi-bukuryo-gan, a kampo medicine, related to plasma calciotonin gene-related peptide level. Maturitas 2003;45:199᾿04.

    Article  CAS  PubMed  Google Scholar 

  44. Noguchi M, Ikarashi Y, Yuzurihara M. Effects of the Japanese herbal medicine Keishi-bukuryo-gan and 17betaestradiol on calcitonin gene-related peptide-induced elevation of skin temperature in ovariectomized rats. J Endocrinol 2003;176:359᾿66.

    Article  CAS  PubMed  Google Scholar 

  45. Sakamoto S, Kudo H, Kawasaki T, Kuwa K, Kasahara N, Sassa S, et al. Effects of a Chinese herbal medicine, Keishi-bukuryo-gan, on the gonadal system of rats. J Ethnopharmacol 1988;23:151᾿58.

    Article  CAS  PubMed  Google Scholar 

  46. Hikiami H, Goto H, Sekiya N, Hattori N, Sakakibara I, Shimada Y, et al. Comparative efficacy of Keishi-bukuryogan and pentoxifylline on RBC deformability in patients with "oketsu" syndrome. Phytomedicine 2003;10:459᾿66.

    Article  CAS  PubMed  Google Scholar 

  47. Goto H, Shimada Y, Sekiya N, Yang Q, Kogure T, Mantani N, et al. Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats. Phytomedicine 2004;11:188᾿95.

    Article  CAS  PubMed  Google Scholar 

  48. Nakagawa T, Yokozawa T, Terasawa K, Nakanishi K. Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy. J Pharm Pharmacol 2003;55:219᾿27.

    Article  CAS  PubMed  Google Scholar 

  49. Sekiya N, Tanaka N, Itoh T, Shimada Y, Goto H, Terasawa K. Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit. Phytother Res 1999;13:192᾿96.

    Article  CAS  PubMed  Google Scholar 

  50. Sekiya N, Goto H, Tazawa K, Oida S, Shimada Y, Terasawa K. Keishi-bukuryo-gan preserves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by limiting superoxide generation. Phytother Res 2002;16:524᾿28.

    Article  CAS  PubMed  Google Scholar 

  51. Fujimoto M, Tsuneyama K, Kinoshita H, Goto H, Takano Y, Selmi C, et al. The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease. Ann N Y Acad Sci (2010);1190:151᾿58.

    Article  CAS  PubMed  Google Scholar 

  52. Nagata Y, Goto H, Hikiami H, Nogami N, Fujimoto M, Shibahara N, et al. Effect of Keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design. Evid Based Complement Alternat Med 2012;2012:359282.

    PubMed Central  PubMed  Google Scholar 

  53. Nozaki K, Hikiami H, Goto H, Nakagawa T, Shibahara N, Shimada Y. Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis. Evid Based Complement Alternat Med 2006;3:359᾿64.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Huang SF, Hou RY, Gao SS, Ni XH, Du TF. Preliminary study on pattern of prescription compatibility of Chinese medicine for treatment of coronary heart disease. J Guangzhou Univ Tradit Chin Med (Chin) 2009;26:305᾿07.

    Google Scholar 

  55. Liu SH, Cheng YC. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol 2012;140:614᾿23.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Traditional Chinese Medicine Health Education and Research Center, 20657 Golden Springs Dr. Suite 108, Diamond Bar, CA, 91789, USA

    Willow J.H. Liu  (柳江华)

Authors
  1. Willow J.H. Liu  (柳江华)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Willow J.H. Liu  (柳江华).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, W.J. What has been overlooked on study of Chinese materia medica in the West?. Chin. J. Integr. Med. 21, 483–492 (2015). https://doi.org/10.1007/s11655-015-2081-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-015-2081-x

Keywords

Search

Navigation